Most men raise it themselves
There is a familiar story about men and this topic: that he will not raise it, that it surfaces at the door on the way out, that the physician has to go looking. In my experience that story is mostly wrong. A great many men book the appointment for this specifically. They describe it plainly, they have usually read about it, and they frequently arrive knowing what they would like to be prescribed.
They are right to ask. The difficulty is not reticence — it is what happens after the asking.
The request is an easy one to grant. There is an effective medication, the man wants it, the appointment is short, and everybody leaves satisfied. What that transaction does is treat the symptom in the place where the symptom appeared. And the place where it appeared is almost never the place with the problem.
A systemic disease that surfaced locally
An erection is a vascular event. It depends on arterial inflow and on endothelium — the single-cell lining that instructs a vessel when to relax and admit more blood. When that lining stops working properly, and when atherosclerosis begins narrowing the vessels behind it, the mechanism fails.
Neither of those processes is local. Endothelial dysfunction and atherosclerosis are diseases of the whole arterial tree, progressing more or less in parallel throughout the body. What is not parallel is when each territory becomes symptomatic — and that difference comes down to diameter.
The arteries supplying erectile tissue are roughly one to two millimeters across. The coronary arteries are three to four. The carotids are larger still. A given amount of plaque, laid down at a similar rate everywhere, consumes a far greater share of a small vessel than a large one. The small vessel therefore loses function first, and it loses it in a way the man notices immediately — while the coronary artery accumulates the same disease silently, because it still has margin to spare.
That is the whole argument, and it is not a fringe position. Erectile dysfunction is an independent predictor of cardiovascular events. The symptom commonly precedes clinically apparent coronary disease by some years, and the lead time typically reported is three to five. The risk factors are not merely similar to the cardiac ones; they are the same list: diabetes and insulin resistance, hypertension, abnormal lipids, smoking, visceral fat, inactivity.
So when a man in his fifties describes new difficulty with erections, he is not only reporting a sexual problem. He may be delivering the earliest symptomatic evidence he will ever get that his arteries are in trouble — years before anything shows up in a place that would frighten him into action.
“The penis is not the organ with the problem. It is the one with the least margin, which is why it reports first.”
Desmond Ebanks, MDWhy the standard visit stops too early
Very little about a conventional appointment is built to act on that.
The medication works, and it works by acting on the same vascular pathway the disease is degrading. It restores the function without altering what is degrading it. That is a legitimate thing to want and I am not against prescribing it. But it resolves the complaint, and a resolved complaint closes the encounter. The arterial question is never asked, because nothing in the visit forces it to be.
What typically does not happen next is the part that mattered: a serious look at lipids — including particle measures like ApoB that a standard panel omits — at glucose and insulin, at blood pressure across the day, at visceral fat, at inflammatory markers, at what the arteries themselves are actually doing. And when cardiovascular screening does follow, it is often the same population-level risk estimate that misclassifies a substantial share of the people who go on to have events.
The result is a man who has been treated, reasonably, for the thing he asked about, and who leaves carrying the risk he came in with — now slightly less likely to be investigated, because the symptom that would have prompted it has been silenced.
Peyronie’s disease is a different condition
This belongs on the same page for one reason only: men routinely conflate the two, and so does a great deal of what is written about them. They are not the same problem and they should not be evaluated the same way.
Peyronie’s disease is a disorder of wound healing, not of blood flow. Fibrous scar tissue forms in the tunica albuginea, the tough sheath surrounding the erectile chambers. It is thought to begin with repetitive microtrauma during ordinary intercourse — injury most men sustain and heal without ever knowing about. In susceptible men, the repair goes wrong: excess collagen, laid down in disorganized fashion, forming a plaque that never properly remodels. The consequences are mechanical — curvature, an indentation or narrowing, loss of length, pain while the process is active.
Susceptibility tracks with other fibrosing conditions, most recognizably Dupuytren’s contracture of the hand, and often runs in families. It moves through two phases: an acute phase of roughly six to eighteen months, during which pain is common and the curve is still changing, and a chronic phase in which the curvature stabilizes and pain usually resolves. Which phase a man is in determines what is appropriate, which is the argument for being examined while it is still evolving.
The two conditions can certainly coexist, and a plaque can compromise rigidity on its own — scarred tissue does not hold pressure. But that is a structural cause, not a vascular one. A man can have significant Peyronie’s with entirely normal arterial inflow, and vascular erectile dysfunction with no plaque whatsoever. Treating them as one entity gets at least one of them wrong.
Where this sits in the work
There is no men’s health service line here. This is not a menu item, not a separate appointment, and not something priced on its own.
Diagnose. When a man raises this, it becomes one input into the evaluation every member receives — a lab panel, body composition, cardiorespiratory fitness, strength, and Vascular Health analysis, reported as a Systemic Vascular Score and a Vascular Age alongside the Healthspan Index. The governing question is not how to relieve the symptom. It is what the arterial system is doing, how long it has been doing it, and what else it is affecting that has not yet announced itself.
Restore. The work goes at the substrate: lipids, glucose and insulin, blood pressure, hormones, sleep, training, body composition. Treating the symptom and treating the arteries are not alternatives — there is no reason a man should have to choose, and most should be doing both.
Sustain. The same measures, repeated over time, so that improvement is demonstrated rather than assumed.
The man who comes in asking for a prescription is asking a reasonable question, and he should get an answer to it. The error is answering only the question he asked.
General clinical information, not medical advice or a diagnosis — new erectile difficulty, or a new, changing, or painful curvature, should be evaluated in person. Lab panels, body composition, and cardiorespiratory testing are established medicine, available anywhere with the equipment and the expertise to interpret them; what differs here is that one physician reads them together, as one picture, and stays accountable for what follows.